MedTech News
.................... by Andrew Celentano
Saluda Medical Receives U.S. FDA Approval for New CAP24™ Surgical Paddle Lead
BLOOMINGTON, Minn., June 30, 2026 /PRNewswire/ — Saluda Medical, Inc. (ASX: SLD, “Saluda” or the “Company”), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Saluda’s CAP24 paddle lead, allowing it to be marketed and sold in the U.S.
Rare Powassan Virus Can Lead to Serious Brain or Spinal Cord Inflammation, and Cases are Rising in the U.S.
Powassan virus spreads through infected ticks, raising concern in Maine and Rhode Island, and symptoms can make the infection dangerous.
Moving Toward Better Tests and Treatments for Lyme Disease
New study finds biomarkers that may someday help clinicians better detect—and possibly cure—early and persistent Borrelia burgdorferi infections
Blood test spots hidden pancreatic cancer after treatment
Sensitive test looking for key genetic mutation detects high-risk patients missed by standard testing
Aurenar gets FDA breakthrough nod for noninvasive neuromod tech
Aurenar announced today that it received FDA breakthrough device designation for its V-Link noninvasive neuromodulation system.
Novocure earns CE mark for Optune Pax pancreatic cancer treatment device
Novocure (Nasdaq:NVCR) announced today that its Optune Pax device for treating pancreatic cancer received CE mark approval.
StarMed wins FDA clearance for RF ablation platform for thyroid nodules
StarMed announced today that it received FDA 510(k) clearance for its platform that delivers radiofrequency (RF) ablation of thyroid nodules.
Could a Common Allergy Pill and Heartburn Medication Combination Really Ease PMS Symptoms?
One current viral health trend on TikTok claims that a combination of two over-the-counter drugs can help manage symptoms during those few days each month. Despite the lack of clinical trials to back up this seemingly odd blend of accessible medications, there is some biological reasoning behind this one.